- Home
- GALT vs SGA Comparison
GALT vs SGA Comparison
Compare GALT & SGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- SGA
- Stock Information
- Founded
- GALT 2000
- SGA 1986
- Country
- GALT United States
- SGA United States
- Employees
- GALT N/A
- SGA N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- SGA Broadcasting
- Sector
- GALT Health Care
- SGA Consumer Discretionary
- Exchange
- GALT Nasdaq
- SGA Nasdaq
- Market Cap
- GALT 83.5M
- SGA 74.2M
- IPO Year
- GALT N/A
- SGA 1992
- Fundamental
- Price
- GALT $2.60
- SGA $12.25
- Analyst Decision
- GALT Buy
- SGA
- Analyst Count
- GALT 2
- SGA 0
- Target Price
- GALT $6.00
- SGA N/A
- AVG Volume (30 Days)
- GALT 1.2M
- SGA 6.2K
- Earning Date
- GALT 08-12-2025
- SGA 08-07-2025
- Dividend Yield
- GALT N/A
- SGA 8.24%
- EPS Growth
- GALT N/A
- SGA N/A
- EPS
- GALT N/A
- SGA 0.55
- Revenue
- GALT N/A
- SGA $111,837,000.00
- Revenue This Year
- GALT N/A
- SGA N/A
- Revenue Next Year
- GALT N/A
- SGA $4.84
- P/E Ratio
- GALT N/A
- SGA $22.21
- Revenue Growth
- GALT N/A
- SGA N/A
- 52 Week Low
- GALT $0.73
- SGA $10.75
- 52 Week High
- GALT $3.90
- SGA $16.57
- Technical
- Relative Strength Index (RSI)
- GALT 70.66
- SGA 51.40
- Support Level
- GALT $1.28
- SGA $12.13
- Resistance Level
- GALT $1.36
- SGA $12.80
- Average True Range (ATR)
- GALT 0.33
- SGA 0.44
- MACD
- GALT 0.18
- SGA -0.05
- Stochastic Oscillator
- GALT 52.40
- SGA 54.40
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About SGA Saga Communications Inc. (FL)
Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets. It derives a majority of its revenue from the sale of advertising for broadcast on its stations.